CN104706919B - 一种治疗体表溃疡的药物组合物 - Google Patents
一种治疗体表溃疡的药物组合物 Download PDFInfo
- Publication number
- CN104706919B CN104706919B CN201510157872.3A CN201510157872A CN104706919B CN 104706919 B CN104706919 B CN 104706919B CN 201510157872 A CN201510157872 A CN 201510157872A CN 104706919 B CN104706919 B CN 104706919B
- Authority
- CN
- China
- Prior art keywords
- ulcer
- parts
- pharmaceutical composition
- body surface
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000025865 Ulcer Diseases 0.000 title claims abstract description 66
- 231100000397 ulcer Toxicity 0.000 title claims abstract description 66
- 238000011282 treatment Methods 0.000 title claims abstract description 51
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 36
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 11
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 239000002674 ointment Substances 0.000 claims description 18
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 9
- 239000012071 phase Substances 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 7
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 6
- 239000003871 white petrolatum Substances 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000003981 vehicle Substances 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 230000001133 acceleration Effects 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000003883 ointment base Substances 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- -1 liquid Paraffin Substances 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 231100000614 poison Toxicity 0.000 abstract description 6
- 239000003440 toxic substance Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 238000005469 granulation Methods 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000029663 wound healing Effects 0.000 abstract description 2
- 238000004904 shortening Methods 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 230000008859 change Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 201000010582 ecthyma Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000010445 Chilblains Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010056340 Diabetic ulcer Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044546 Traumatic ulcer Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Abstract
Description
组别 | 溃疡个数 | 痊愈 | 显效 | 有效 | 无效 | 有效率 |
治疗组 | 46 | 43(93.48%) | 2(4.34%) | 1(2.17%) | 0 | 97.83% |
对照组 | 45 | 29(64.44%) | 7(15.56%) | 8(17.78%) | 1 | 80% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510157872.3A CN104706919B (zh) | 2015-04-06 | 2015-04-06 | 一种治疗体表溃疡的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510157872.3A CN104706919B (zh) | 2015-04-06 | 2015-04-06 | 一种治疗体表溃疡的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104706919A CN104706919A (zh) | 2015-06-17 |
CN104706919B true CN104706919B (zh) | 2016-03-09 |
Family
ID=53406963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510157872.3A Expired - Fee Related CN104706919B (zh) | 2015-04-06 | 2015-04-06 | 一种治疗体表溃疡的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104706919B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105748699A (zh) * | 2016-03-16 | 2016-07-13 | 张金爱 | 一种用于治疗体表溃疡的护理药物制剂及其用途 |
CN105816514A (zh) * | 2016-04-07 | 2016-08-03 | 王键 | 一种护理慢性体表溃疡的药物组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104536A (zh) * | 1994-06-14 | 1995-07-05 | 龚俊烈 | 抗溃特效速愈散 |
CN102552606A (zh) * | 2011-12-03 | 2012-07-11 | 彭旦明 | 一种用于治疗慢性体表溃疡的药物组合物及其制备方法 |
CN102688383A (zh) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | 一种用于治疗体表溃疡或溃烂的中药组合物 |
-
2015
- 2015-04-06 CN CN201510157872.3A patent/CN104706919B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104536A (zh) * | 1994-06-14 | 1995-07-05 | 龚俊烈 | 抗溃特效速愈散 |
CN102552606A (zh) * | 2011-12-03 | 2012-07-11 | 彭旦明 | 一种用于治疗慢性体表溃疡的药物组合物及其制备方法 |
CN102688383A (zh) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | 一种用于治疗体表溃疡或溃烂的中药组合物 |
Non-Patent Citations (3)
Title |
---|
中医治疗下肢溃疡近况与展望;高晓钢;《陕西中医》;19961231;第17卷(第11期);524-526 * |
小腿慢性溃疡的临床治疗与研究进展;周华君;《四川中医》;19951231(第12期);13-15 * |
皮肤溃疡的中药外治近况;王春丽等;《中医外治杂志》;20041231;第13卷(第6期);40-42 * |
Also Published As
Publication number | Publication date |
---|---|
CN104706919A (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884770B (zh) | 治疗尿石症的中药制剂及其制备方法 | |
CN104523865B (zh) | 一种治疗乳腺疾病的药物 | |
CN104706919B (zh) | 一种治疗体表溃疡的药物组合物 | |
CN102631464B (zh) | 一种治疗婴幼儿血管瘤的中药膏剂及其制备方法 | |
CN102552804B (zh) | 一种治疗跖疣的中药组合物 | |
CN101569738A (zh) | 一种治疗乳腺炎、乳腺增生、乳房肿块、关节积液、跌打损伤的膏药及其制备方法与应用 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN103330873A (zh) | 一种蛇伤康复药 | |
CN103330872A (zh) | 一种蛇伤康复药的制备方法 | |
CN105770691A (zh) | 一种用于治疗宫颈癌的药物制剂及其用途 | |
CN103239677B (zh) | 一种用于治疗腹水的肛肠用药及其制剂的制备方法 | |
CN101961455A (zh) | 一种治疗慢性结肠炎疾病的中药 | |
CN110812463A (zh) | 一种治疗盆腔炎的中药灌肠药剂及其制备方法 | |
CN103520447A (zh) | 一种适用于肛瘘术后的外用膏剂 | |
CN1290541C (zh) | 胎茸健肾补血膏及制作方法 | |
CN100353995C (zh) | 一种具有祛风活络解毒的药物组合物 | |
CN106822524B (zh) | 用于治疗不孕症的复方药物及其制备方法和应用 | |
CN105833020A (zh) | 一种促进术后创面愈合的外用护理药物组合物 | |
CN105327290A (zh) | 一种治疗糖尿病坏疽的外用中药及其制备方法 | |
CN105343707A (zh) | 一种治疗离心性环状红斑的中药 | |
CN105748699A (zh) | 一种用于治疗体表溃疡的护理药物制剂及其用途 | |
CN104587141A (zh) | 用于治疗重度宫颈糜烂的凝胶剂及其制备方法 | |
CN104587399A (zh) | 治疗卵巢囊肿的中药配方 | |
CN109260419A (zh) | 一种治疗乳腺增生的黑膏药及其制备方法 | |
CN104042875B (zh) | 一种中药组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Tian Shixia Inventor after: Dai Yanhua Inventor after: Ding Li Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160216 Address after: Zhongxing Road, Chengguan 277700 Shandong province Linyi Lanling County No. 86 Applicant after: Tian Shixia Address before: 266109 Shandong, Qingdao, Chengyang District, No. 825 Zhengyang Road, building, room 1, office, room 205 Applicant before: The skies, Qingdao Bioisystech Co., Ltd |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170802 Address after: Lin Zhen Miao village in Shandong city of Dezhou province Fuan 251511 Linyi County No. 28 Patentee after: Zheng Hongmei Address before: Zhongxing Road, Chengguan 277700 Shandong province Linyi Lanling County No. 86 Patentee before: Tian Shixia |
|
TR01 | Transfer of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: 266700 South Outer Ring Road No. 2, Cui Jia town, Pingdu City, Qingdao, Shandong Patentee after: Zheng Hongmei Address before: Lin Zhen Miao village in Shandong city of Dezhou province Fuan 251511 Linyi County No. 28 Patentee before: Zheng Hongmei |
|
CP02 | Change in the address of a patent holder | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160309 Termination date: 20180406 |